XML 13 R2.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Investments:    
Fixed maturities available-for-sale, at fair value (amortized cost: $170.6 million and $164.6 million, respectively) $ 167.0 $ 161.7
Short-term investments, at fair value (amortized cost: $148.5 million and $187.1 million, respectively) 148.5 187.1
Total investments 315.5 348.8
Cash and cash equivalents 175.9 142.1
Restricted cash 44.3 53.0
Accounts receivable, net of allowance of $0.5 million and $0.5 million, respectively 167.4 145.2
Reinsurance recoverable on paid and unpaid losses and LAE 290.8 281.3
Prepaid reinsurance premiums 291.3 335.6
Ceding commissions receivable 81.7 73.8
Capitalized internal use software 49.9 48.4
Intangible assets 25.0 27.3
Other assets 68.5 69.2
Total assets 1,510.3 1,524.7
Liabilities:    
Loss and loss adjustment expense reserve 346.9 322.5
Unearned premiums 452.7 419.2
Reinsurance premiums payable 246.6 260.1
Provision for commission 31.3 24.7
Accrued expenses and other liabilities 106.2 113.5
Total liabilities 1,183.7 1,140.0
Commitments and contingencies (Note 12)
Stockholders’ equity:    
Common stock, $0.0001 par value per share; 80,000,000 and 80,000,000 shares authorized as of June 30, 2024 and December 31, 2023, respectively; 24,891,528 and $24,148,308 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively 0.0 0.0
Additional paid-in capital 1,636.8 1,615.2
Accumulated other comprehensive loss (3.6) (2.9)
Accumulated deficit (1,310.6) (1,234.4)
Total Hippo stockholders’ equity 322.6 377.9
Noncontrolling interest 4.0 6.8
Total stockholders’ equity 326.6 384.7
Total liabilities and stockholders’ equity $ 1,510.3 $ 1,524.7